NASDAQ:ADUSAddus Homecare Stock Price, Forecast & News

Addus Homecare's stock was trading at $67.64 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ADUS shares have increased by 32.5% and is now trading at $89.60. View which stocks have been most impacted by Coronavirus.

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Addus Homecare in the last year. There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Addus Homecare.

Addus Homecare is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Addus Homecare.

Addus Homecare Co. (NASDAQ:ADUS) posted its quarterly earnings results on Monday, May, 4th. The company reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.56 by $0.13. The business earned $190.20 million during the quarter, compared to analysts' expectations of $181.08 million. View Addus Homecare's earnings history.

Addus Homecare updated its first quarter 2020 After-Hours earnings guidance on Monday, May, 4th. The company provided earnings per share (EPS) guidance of 0.77-0.77 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.63. The company issued revenue guidance of $190.2-190.2 million, compared to the consensus revenue estimate of $179.06 million.

8 brokers have issued 1 year price objectives for Addus Homecare's stock. Their forecasts range from $85.00 to $115.00. On average, they anticipate Addus Homecare's stock price to reach $99.57 in the next twelve months. This suggests a possible upside of 11.1% from the stock's current price. View analysts' price targets for Addus Homecare.

News coverage about ADUS stock has trended somewhat negative this week, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Addus Homecare earned a coverage optimism score of -1.2 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news about Addus Homecare.

Some companies that are related to Addus Homecare include Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), Option Care Health (OPCH) and New York Health Care (BBAL). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus Homecare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), Cisco Systems (CSCO), CVS Health (CVS), Ulta Beauty (ULTA), Alibaba Group (BABA) and Walt Disney (DIS).

Addus Homecare trades on the NASDAQ under the ticker symbol "ADUS."

Addus Homecare's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Envestnet Asset Management Inc. (0.05%) and 6 Meridian (0.02%). Company insiders that own Addus Homecare stock include Brian Poff, Darby Anderson, David W Tucker, Eos Capital Partners Iii L P, James Zoccoli, Laurie Manning, Mark L First, R Dirk Allison, Sean Gaffney, Susan T Weaver and W Bradley Bickham. View institutional ownership trends for Addus Homecare.

ADUS stock was sold by a variety of institutional investors in the last quarter, including 6 Meridian, and Envestnet Asset Management Inc.. Company insiders that have sold Addus Homecare company stock in the last year include Brian Poff, Darby Anderson, David W Tucker, Laurie Manning, Mark L First, R Dirk Allison, Sean Gaffney, Susan T Weaver, and W Bradley Bickham. View insider buying and selling activity for Addus Homecare.

Shares of ADUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ADUS stock can currently be purchased for approximately $89.60.

Addus Homecare has a market capitalization of $1.39 billion and generates $518.12 million in revenue each year. Addus Homecare employs 33,153 workers across the globe.

The official website for Addus Homecare is www.addus.com.

Addus Homecare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The company can be reached via phone at 469-535-8200 or via email at [email protected]